Omekril 60 capsules from Novadiet

0.00 €

Not in stock

piece(s)

Description

Food supplement based on fish liver oils and Krill. It contributes to maintain the normal functioning of the brain.

Nutrition and health claims:

Natural source of Vitamin D.
High natural content of Vitamin A.
Docosahexaenoic acid (DHA) helps maintain normal brain function and maintain vision under normal conditions. The beneficial effect is obtained with a daily intake of 250 mg of DHA.
Eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) contribute to the normal functioning of the heart. The beneficial effect is obtained with a daily intake of 250 mg of EPA and DHA.

Ingredients: Per daily dose = 3 capsules: Fish liver oil: 1200 mg. Krill oil: 300 mg. EPA: 113 mg. DHA: 282 mg. Omega 3: 420 mg. Vitamin A: 672 μg (84% VRN *). Vitamin D: 1.1 μg (22% NRV *). Astaxanthin: 30 μg. * VRN: Nutrient Reference Values

Directions: Take a capsule with breakfast, lunch and dinner, with the help of water or fruit juice.

Caution: Do not take this food supplement if you are allergic or intolerant to any of its ingredients. If you are being treated with anticoagulants or platelet antiaggregants, you should consult a health professional.

More info about the product composition: Krill is a crustacean that measures just 3 cm. long and weighs 2 gr. Reduces cholesterol and triglyceride levels, preventing cardiovascular diseases. An oil is extracted from krill, consisting of Omega 3 fatty acids, phospholipids, choline, Vitamin A and E, and in a smaller proportion Omega 6 and 9. It also contains astaxanthin, a powerful antioxidant responsible for the reddish color of krill. The omega-3 EPA and DHA contained in the lipid extract of Krill are in the form of phospholipids. DHA helps maintain normal brain function and contributes to the maintenance of vision under normal conditions. Maintaining an optimal level of DHA can prevent cognitive deterioration caused by age. People who maintain optimal levels of EPA and DHA, two Omega-3 fatty acids, improve blood flow to the brain, according to research published in the Journal of Alzheimer's Disease.